New Delhi, Nov 21 (IANS) Health-tech company PharmEasy has clocked Rs 2,533 crore in losses last fiscal (FY24), as it revenue declined almost 15 per cent at Rs 5,664 crore.
The revenue from operations decreased 14.8 per cent to Rs 5,664 crore compared to Rs 6,644 crore in FY23, as per the financials of API Holdings, the parent company of PharmEasy.
The company, which substantially cut its workforce last year amid deep valuation cuts, managed to reduce losses by over 50 per cent in FY24, owing to 79 per cent reduction in goodwill impairment charges.
The goodwill impairment is an accounting charge that companies record when goodwill’s carrying value on financial statements exceeds its fair value.
On a unit level, PharmEasy spent Rs 1.28 to earn a rupee in FY24, according to its financials.
Once valued at $5 billion, PharmEasy saw its valuation nosedive to about $500-$600 million last year. It had raised around $1.1 billion t date.
The cost of materials went down 14.8 per cent to Rs 4,880.3 crore in FY24 and the finance cost went up 9.4 per cent to Rs 727.9 crore.
PharmEasy incurred Rs 699.3 crore on employee benefits last fiscal, which included ESOP cost worth Rs 221.8 crore.
Last year, the online pharmacy startup PharmEasy went into deep crisis amid sharp valuation cut as it sought new funding.
The healthtech company also defaulted on a Rs 3,500 crore loan from Goldman Sachs in June last year, and even postponed its listing plan in August 2022 after filing IPO papers in November 2021.
In April this year, it had a 90 per cent haircut in its valuation after it secured around $216 million funding led by Manipal Education and Medical Group (MEMG) and existing investors.
–IANS
na/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
